MENU
APTOF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Aptose Biosciences (APTOF) Ownership - Who owns Aptose Biosciences?
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.62M
P/E Ratio
N/A
Total Cash
3.32M
Projected Growth
N/A
Total Debt
10.72M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APTOF
Capitalization
8.62M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.32M
Total Cash/Share
1.30
Total Debt
10.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-9.13M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-36.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
452M
Current Ratio
1.05
Current Revenue Per Employee
101.93
Dividends Per Share - Security
N/A
EBITDA
-24.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-220.02
Shares Held By Institutions
N/A
Shares Outstanding - Current
2.55M
Total Liabilities
20.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
1231.558
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of anticancer therapies with high safety profiles
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A